SOPHIE-CHARLOTTE 
HOFFERBERTH, MD

Chief Executive Officer, Co-Founder

Dr Sophie-Charlotte Hofferberth is the Chief Executive Officer and Co-founder of Autus Valve Technologies, Inc. As a post-doctoral research fellow in the Department of Cardiac Surgery at Boston Children’s Hospital, Dr Hofferberth led the conception, design and development of the novel Autus Size-Adjustable Valve technology. Dr Hofferberth designed and led the pre-clinical bench and animal studies that culminated in FDA approval for a U.S Early Feasibility Study and successful performance of the first-in-human Autus Valve implant.
Dr Hofferberth received her medical degree from the University of Melbourne Medical School and she is a cardiothoracic surgery resident at Brigham and Women’s Hospital, Harvard Medical School. Dr Hofferberth has taken a leave of absence from her surgical training to lead the development of the Autus Valve.